The scientific and educational conference, Nephrocardiology 2023, took place on April 21-22 at the Branicki Palace in Białystok. The conference consisted of six sessions, during which the pathomechanisms and the latest therapeutic possibilities for cardiovascular complications in patients with chronic kidney disease were discussed. During the conference, non-renal aspects of sodium-glucose cotransporter 2 (SGLT2) inhibitors were presented, new methods of hyperlipidemia treatment were discussed, and the issue of obesity and metabolic syndrome in the context of qualification for kidney transplantation was addressed. There were also topics related to genetics - genetic causes of obesity and the issue of metabolism programming were presented. The relationship between dysbiosis and hypertension, as well as the pathomechanism and consequences of congestive nephropathy, have been discussed. Additionally, estimates of the costs of cardiovascular care in dialysis patients were presented, as well as the potential for individualizing hemodialysis therapy in the future. New methods of vasculitis treatment have also been presented.